"Das Helios Klinikum Uelzen ist ein akademisches Lehrkrankenhaus der Medizinischen Hochschule Hannover (MHH) und versorgt mit etwa 750 Mitarbeitern jährlich rund 17.000 stationäre und 25.000 ambulante Patienten."

During the past decade, Klinikum Uelzen GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Uelzen GmbH" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Uelzen GmbH" are "Congestive Heart Failure" (1 trials), "Heart Failure" (1 trials), "Left Ventricular Systolic Dysfunction" (1 trials) and "Sleep Disordered Breathing" (1 trials). Many other conditions were trialed in "Klinikum Uelzen GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Uelzen GmbH" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Uelzen GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Uelzen GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Uelzen GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Uelzen GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".